Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Lum, Christopher T.
and
Stahl, Stephen M.
2012.
Opportunities for reversible inhibitors of monoamine oxidase-A (RIMAs) in the treatment of depression.
CNS Spectrums,
Vol. 17,
Issue. 3,
p.
107.
Alexander, Earnest
Susla, Gregory M.
Cooper, Brad E.
and
Sejnowski, Celeste A.
2013.
Serotonin Syndrome: Recognition and Treatment.
AACN Advanced Critical Care,
Vol. 24,
Issue. 1,
p.
15.
Alexander, Earnest
Susla, Gregory M.
Cooper, Brad E.
and
Sejnowski, Celeste A.
2013.
Serotonin Syndrome: Recognition and Treatment.
AACN Advanced Critical Care,
Vol. 24,
Issue. 1,
p.
15.
Klein, Donald F.
and
Arden, Peter C.
2014.
Early Development of Monoamine Oxidase Inhibitors.
Psychiatric Annals,
Vol. 44,
Issue. 12,
p.
563.
Palhano-Fontes, Fernanda
Alchieri, Joao C.
Oliveira, Joao Paulo M.
Soares, Bruno Lobao
Hallak, Jaime E. C.
Galvao-Coelho, Nicole
and
de Araujo, Draulio B.
2014.
The Therapeutic Use of Ayahuasca.
p.
23.
Tao, Rui
Rudacille, Mary
Zhang, Gongliang
and
Ma, Zhiyuan
2014.
Changes in Intensity of Serotonin Syndrome Caused by Adverse Interaction between Monoamine Oxidase Inhibitors and Serotonin Reuptake Blockers.
Neuropsychopharmacology,
Vol. 39,
Issue. 8,
p.
1996.
Culpepper, Larry
Muskin, Philip R.
and
Stahl, Stephen M.
2015.
Major Depressive Disorder: Understanding the Significance of Residual Symptoms and Balancing Efficacy with Tolerability.
The American Journal of Medicine,
Vol. 128,
Issue. 9,
p.
S1.
Thomas, Samantha J.
Shin, Mirae
McInnis, Melvin G.
and
Bostwick, Jolene R.
2015.
Combination Therapy with Monoamine Oxidase Inhibitors and Other Antidepressants or Stimulants: Strategies for the Management of Treatment‐Resistant Depression.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy,
Vol. 35,
Issue. 4,
p.
433.
Bied, Adam M
Kim, Jungjin
and
Schwartz, Thomas L
2015.
A critical appraisal of the selegiline transdermal system for major depressive disorder.
Expert Review of Clinical Pharmacology,
Vol. 8,
Issue. 6,
p.
673.
Amr, Abd El-Galil E
Omar, Mohamed A. Al-
and
Abdalla, Mohamed M.
2016.
Monoamino Oxidase Inhibitors Activities of Some Synthesized 2,6-bis (Tetracarboxamide)-pyridine and Macrocyclic Octacarboxamide Derivatives.
International Journal of Pharmacology,
Vol. 12,
Issue. 2,
p.
66.
Laux, Gerd
2016.
Psychiatrie, Psychosomatik, Psychotherapie.
p.
1.
Julius, Anthony
and
Longfellow, Katelan
2016.
Movement Disorders.
Medical Clinics of North America,
Vol. 100,
Issue. 4,
p.
733.
Kelberman, Michael A.
and
Vazey, Elena M.
2016.
New Pharmacological Approaches to Treating Non-Motor Symptoms of Parkinson’s Disease.
Current Pharmacology Reports,
Vol. 2,
Issue. 6,
p.
253.
Margret, Anita
2017.
Advancing Medicine through Nanotechnology and Nanomechanics Applications.
p.
250.
Entzeroth, Michael
and
Ratty, Anil K.
2017.
Monoamine Oxidase Inhibitors—Revisiting a Therapeutic Principle.
Open Journal of Depression,
Vol. 06,
Issue. 02,
p.
31.
2017.
The Greening of Pharmaceutical Engineering.
p.
423.
Margret, Anita
2017.
Pharmaceutical Sciences.
p.
1367.
Mladenović, Milan
Patsilinakos, Alexandros
Pirolli, Adele
Sabatino, Manuela
and
Ragno, Rino
2017.
Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2H-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative Structure–Activity Relationships Predictive Models.
Journal of Chemical Information and Modeling,
Vol. 57,
Issue. 4,
p.
787.
Laux, Gerd
2017.
Psychiatrie, Psychosomatik, Psychotherapie.
p.
1711.
Margret, Anita
2017.
Materials Science and Engineering.
p.
1780.